University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Transforming Research and Clinical Knowledge in Spinal Cord Injury

Conditions: Spinal Cord Injuries

First Posted Date: 2020-09-25

Last Posted Date: 2023-07-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 726

Registration Number: NCT04565366

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of California, San Francisco - Fresno, Fresno, California, United States

and more 2 locations

TB Screening Improves Preventive Therapy Uptake

Not Applicable

Active, not recruiting

Conditions: Latent Tuberculosis
HIV
Tuberculosis
Tuberculosis Prevention

Interventions: Device: CRP, point-of-care assay

First Posted Date: 2020-09-21

Last Posted Date: 2023-11-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1719

Registration Number: NCT04557176

Locations: 🇺🇬
Kampala Capital City Authority Clinic, Kampala, Uganda

Social & Contextual Impact on Children Undergoing Liver Transplantation

Recruiting

Conditions: Liver Transplantation
Liver Diseases

First Posted Date: 2020-09-16

Last Posted Date: 2023-06-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 500

Registration Number: NCT04551742

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

and more 5 locations

A Study of Adolescents Undergoing a Mindfulness Training During COVID-19

Not Applicable

Completed

Conditions: Healthy

Interventions: Behavioral: Training for Awareness, Resilience, and Action (TARA)

First Posted Date: 2020-09-14

Last Posted Date: 2024-12-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 21

Registration Number: NCT04548544

Locations: 🇺🇸
UCSF, San Francisco, California, United States

mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer

Not Applicable

Completed

Conditions: Metastatic Prostate Cancer

Interventions: Other: Medcorder

First Posted Date: 2020-09-11

Last Posted Date: 2021-06-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 27

Registration Number: NCT04545697

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Predicting Inflammatory Skin Disease Response to IL-23 Blockade

Phase 4

Completed

Conditions: Psoriasis Vulgaris

Interventions: Biological: Tildrakizumab

First Posted Date: 2020-09-09

Last Posted Date: 2024-04-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 7

Registration Number: NCT04541329

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)

Phase 1

Active, not recruiting

Conditions: Healthy Volunteers

Interventions: Drug: Rosuvastatin (Inhibitor arm)
Drug: Rosuvastatin
Drug: Eltrombopag

First Posted Date: 2020-09-09

Last Posted Date: 2024-01-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT04542382

Locations: 🇺🇸
Ucsf Ctsi Crc, San Francisco, California, United States

Dexamethasone Solution and Dexamethasone in Mucolox™

Phase 2

Completed

Conditions: Oral Lichen Planus
Mucous Membrane Pemphigoid
Pemphigus Vulgaris
Chronic Graft-versus-host-disease

Interventions: Drug: dexamethasone 0.5mg/5ml solution in Mucolox™
Drug: dexamethasone 0.5mg/5ml solution

First Posted Date: 2020-09-07

Last Posted Date: 2023-12-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 29

Registration Number: NCT04540133

Locations: 🇺🇸
Sol Silverman Oral Medicine Clinic - UCSF, San Francisco, California, United States

Excipient Effect on Drug Absorption in Humans

Early Phase 1

Recruiting

Conditions: The Impact of Excipients on Drug Absorption

Interventions: Drug: Fexofenadine Hydrochloride with sodium lauryl sulfate
Drug: Fexofenadine Hydrochloride without sodium lauryl sulfate

First Posted Date: 2020-09-01

Last Posted Date: 2024-06-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT04534153

Locations: 🇺🇸
Ucsf Ctsi Crc, San Francisco, California, United States

In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseases

Phase 1

Recruiting

Conditions: Gaucher Disease, Type 2
Wolman Disease
MPS II
MPS IVA
MPS VI
Mps VII
Pompe Disease Infantile-Onset
MPS I
Gaucher Disease, Type 3

Interventions: Drug: Aldurazyme (laronidase)

First Posted Date: 2020-08-31

Last Posted Date: 2023-09-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT04532047

Locations: 🇺🇸
University of California, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy